INKT - MiNK Therapeutics, Inc.
10.28
-0.670 -6.518%
Share volume: 6,221
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$10.95
-0.67
-0.06%
Summary score
33%
Profitability
35%
Dept financing
43%
Liquidity
31%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-39.37%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
372.73%
Debt ratio change over timeo
0%
Current Ratio
0.74%
Quick Ratio
0%
Cash Position Ratio
0.71%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-42.85%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
414.44%
Debt ratio change over timeo
0%
Current Ratio
0.7%
Quick Ratio
0%
Cash Position Ratio
0.66%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-19.67%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
190.31%
Debt ratio change over time
0%
Current Ratio
1.08%
Quick Ratio
0%
Cash Position Ratio
1.06%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INKT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 28.34% | 5.51% | 6.15% |
| Return on assets | -39.37% | 3.06% | 3.18% | 2.21% |
| Return on sales | 0% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | 0% | 6.42% | 3.22% | 6.7% |
| Profitability | 0% | 98% | 66% | 68% |
| Total debt ratio | 372.73% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | 0% | 12.76% | 169.64% | 13.01% |
| Dept financing | 25% | 8% | 29% | 5% |
| Current Ratio | 0.7% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 0.66% | 0.43% | 0.63% | 0.74% |
| Liquididy | 31% | 64% | 50% | 72% |
| Short-term ratios | INKT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -42.85% | 3.09% | 4.74% | 1.98% |
| Return on sales | 0% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 33% | 50% | 26% |
| Total debt ratio | 414.44% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 6% | 4% | 2% |
| Current Ratio | 0.7% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 0.66% | 0.43% | 0.63% | 0.74% |
| Liquididy | 31% | 47% | 62% | 75% |